Steven Devine
NMDP · NMDP/Be The Match · National Marrow Donor Program
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Steven Devine as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 16:07 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07563010 · Menin-Inhibitor Targeted Maintenance in AMLCenter for International Blood and Marrow Transplant Research · not yet recruiting · Relapsed Adult AML, Stem Cell Transplant Complications, Acute Myeloid Leukemia · study chair
- Ph2NCT06001385 · HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisCenter for International Blood and Marrow Transplant Research · active not recruiting · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia · principal investigator
- Ph2NCT04904588 · HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideCenter for International Blood and Marrow Transplant Research · active not recruiting · Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia · principal investigator
- Ph2NCT04762875 · MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic MalignanciesEnsoma · terminated · Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia · study chair
- Ph1NCT00677859 · Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or MyelodysplasiaHealios K.K. · completed · Hematologic Malignancies · principal investigator
- Ph2NCT00201240 · Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)National Heart, Lung, and Blood Institute (NHLBI) · completed · Leukemia, Myelocytic, Acute · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 16:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical Protocol and Data Management (Core 017)P30CA016058 · NCI · OHIO STATE UNIVERSITY · fiscal years 2016 to 2020 · $548,311 awarded in 2020Same name and institution; not confirmed by an ID
- The Ohio State Blood and Marrow Transplant Reseach ConsortiumU10HL109322 · NHLBI · OHIO STATE UNIVERSITY · fiscal years 2011 to 2016 · $151,193 awarded in 2016Same name and institution; not confirmed by an ID
- Training Hematology and Oncology Fellows in Clinical ResearchT32CA165998 · NCI · OHIO STATE UNIVERSITY · fiscal years 2012 to 2015 · $206,695 awarded in 2015Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Blood and Marrow Transplant Clinical Trials NetworkU01HL069254 · NHLBI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI Michael A Pulsipher · fiscal years 2001 to 2010Named on NCT00201240
- Random Trial of CD8 T-Cell Depletion in PBSC TransplantationU01HL069249 · NHLBI · DANA-FARBER CANCER INST · PI JOSEPH H ANTIN · fiscal years 2001 to 2010Named on NCT00201240
- Blood and Marrow Transplant Clinical Research NetworkU01HL069278 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Stephen J Forman · fiscal years 2001 to 2010Named on NCT00201240
- BMT Clinical Research Network Data Coordinating CenterU01HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Mary Maresca Horowitz · fiscal years 2001 to 2010Named on NCT00201240
- IL-7 FOR IMMUNE RECOVERY AFTER HEMATOPOIETIC ALLOGRAFTSU01HL069315 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI Sergio A Giralt · fiscal years 2001 to 2010Named on NCT00201240
- NHLBI Blood /Marrow Transplant Clinical Research NetworkU01HL069348 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI HILLARD M LAZARUS · fiscal years 2001 to 2010Named on NCT00201240
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 16:07 UTC. The ranking covers the 200 most relevant of 111 PubMed records, and a shared surname and initials can bring in a namesake. All 111 on PubMed
- Lenalidomide after stem-cell transplantation for multiple myeloma.N Engl J Med · 2012918 citationsRCR 24.3
- Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.Biol Blood Marrow Transplant · 2005621 citationsRCR 14.5
- Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.J Clin Oncol · 2017572 citationsRCR 20.7
- 460 citationsRCR 12.9
- 458 citationsRCR 11.5
- Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.Proc Natl Acad Sci U S A · 2010394 citationsRCR 8.9
- 376 citationsRCR 9.5
- 356 citationsRCR 7.3
- Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.J Clin Oncol · 2004330 citationsRCR 6.0
- Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.J Clin Oncol · 2007258 citationsRCR 5.3